IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $0 | – | 700 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 700 | +4.6% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 669 | -89.6% | 0.00% | – |
Q2 2015 | $3,000 | 0.0% | 6,417 | -2.7% | 0.00% | – |
Q1 2015 | $3,000 | -57.1% | 6,595 | -27.0% | 0.00% | – |
Q4 2014 | $7,000 | -63.2% | 9,032 | -56.6% | 0.00% | – |
Q3 2014 | $19,000 | -24.0% | 20,809 | -8.3% | 0.00% | – |
Q2 2014 | $25,000 | -83.1% | 22,685 | -85.8% | 0.00% | -100.0% |
Q4 2013 | $148,000 | -62.8% | 160,103 | +3.4% | 0.00% | -75.0% |
Q3 2013 | $398,000 | +347.2% | 154,815 | +238.6% | 0.01% | +300.0% |
Q2 2013 | $89,000 | – | 45,722 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |